A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
Status:
Not yet recruiting
Trial end date:
2026-05-23
Target enrollment:
Participant gender:
Summary
To evaluate the safety, tolerability, and DLTs and determine the MTD and/or RDE(s) of
INCA33890 in participants with select advanced or metastatic solid tumors.